Gaetano et al. [24] found no difference in the survival curves of C1qA-/- C57BL/6 mice that had been xenografted with EL4-CD20+ cells (a lymphoma cell line of EL4 stably expressing the human CD20 antigen) and did or did not receive treatment with Rituximab. The gene discussed is C1QA; the disease is lymphoma.